Low serum 25-hydroxyvitamin D concentrations associate with non-alcoholic fatty liver disease in adolescents independent of adiposity

Journal of Gastroenterology and Hepatology (Australia)

Volumn 29, Issue 6, 2014, Pages 1215-1222

  Black, Lucinda J ^a   Jacoby, Peter ^a   She Ping Delfos, Wendy Chan ^b   Mori, Trevor A ^b   Beilin, Lawrence J ^b   Olynyk, John K ^b,d,e,f   Ayonrinde, Oyekoya T ^b,d,e   Huang, Rae Chi ^a,b   Holt, Patrick G ^a,g   Hart, Prue H ^a   Oddy, Wendy H ^a   Adams, Leon A ^b,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

^e CURTIN UNIVERSITY   (Australia)

^f MURDOCH UNIVERSITY   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

25 hydroxyvitamin D; Non alcoholic fatty liver disease; Obesity

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; VITAMIN D;

ADOLESCENT; ARTICLE; BODY MASS; COMPUTER VIEWING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING EQUIPMENT; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE; RECREATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX; TELEVISION VIEWING; ULTRASOUND ARRAY PROBE; ULTRASOUND SCANNER; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK;

ADIPOSITY; ADOLESCENT; BIOLOGICAL MARKERS; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PREVALENCE; PROSPECTIVE STUDIES; RISK; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84900525202     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12541     Document Type: Article

References (45)

1. Caldwell SH, Crespo DM. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. J. Hepatol. 2004; 40: 578-584.
2. Della Corte C, Alisi A, Saccari A, De Vito R, Vania A, Nobili V. Nonalcoholic fatty liver in children and adolescents: an overview. J. Adolesc. Health 2012; 51: 305-312.
3. Chalasani N, Younossi Z, Lavine JE etal. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
4. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393.
5. Cashman KD, Muldowney S, McNulty B etal. Vitamin D status of Irish adults: findings from the National Adult Nutrition Survey. Br. J. Nutr. 2012; 109: 1248-1256.
6. Daly RM, Gagnon C, Lu ZX etal. Prevalence of vitamin D deficiency and its determinants in Australian adults aged 25 years and older: a national, population-based study. Clin. Endocrinol. (Oxf) 2012; 77: 26-35.
7. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr. Res. 2011; 31: 48-54.
8. Whiting SJ, Langlois KA, Vatanparast H, Greene-Finestone LS. The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am. J. Clin. Nutr. 2011; 94: 128-135.
9. Andersen R, Molgaard C, Skovgaard LT etal. Teenage girls and elderly women living in northern Europe have low winter vitamin D status. Eur. J. Clin. Nutr. 2005; 59: 533-541.
10. Looker AC, Johnson CL, Lacher DA, Pfeiffer CM, Schleicher RL, Sempos CT. Vitamin D status: United States, 2001-2006. NCHS Data Brief 2011; 59: 1-8.
11. Pittas AG, Chung M, Trikalinos T etal. Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 2010; 152: 307-314.
12. Adams JS, Hewison M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010; 95: 471-478.
13. Geier A. Shedding new light on vitamin D and fatty liver disease. J. Hepatol. 2011; 55: 273-275.
14. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1, 25-dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab. Res. Rev. 2008; 24: 459-464.
15. George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet. Med. 2012; 29: 142-150.
16. Manco M, Ciampalini P, Nobili V. Low levels of 25-hydroxyvitamin D(3) in children with biopsy-proven nonalcoholic fatty liver disease. Hepatology 2010; 51: 2229.
17. Jablonski KL, Jovanovich A, Holmen J etal. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 2013; 23: 792-798.
18. Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J. Obes. 2010; 2010: 496829.
19. Barchetta I, Angelico F, Del Ben M etal. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011; 9: 85.
20. Targher G, Bertolini L, Scala L etal. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 2007; 17: 517-524.
21. Li L, Zhang L, Pan S, Wu X, Yin X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Dig. Dis. Sci. 2013; 58: 2376-2382.
22. Rhee EJ, Kim MK, Park SE etal. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr. J. 2013; 60: 743-752.
23. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42: 44-52.
24. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J. Pediatr. 2000; 136: 727-733.
25. Newnham JP, Evans SF, Michael CA, Stanley FJ, Landau LI. Effects of frequent ultrasound during pregnancy: a randomised controlled trial. Lancet 1993; 342: 887-891.
26. Hamaguchi M, Kojima T, Itoh Y etal. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 2007; 102: 2708-2715.
27. Ayonrinde OT, Olynyk JK, Beilin LJ etal. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53: 800-809.
28. Baghurst KI, Record SJ. A computerised dietary analysis system for use with diet diaries or food frequency questionnaires. Community Health Stud. 1984; 8: 11-18.
29. Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am. J. Clin. Nutr. 2008; 88: 507S-510.
30. Maunsell Z, Wright DJ, Rainbow SJ. Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. Clin. Chem. 2005; 51: 1683-1690.
31. Hollams EM, Hart PH, Holt BJ etal. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur. Respir. J. 2011; 38: 1320-1327.
32. van der Mei IA, Ponsonby AL, Dwyer T etal. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J. Neurol. 2007; 254: 581-590.
33. Holick MF, Binkley NC, Bischoff-Ferrari HA etal. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 2011; 96: 1911-1930.
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
35. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
36. Cole TJ, Flegal KM, Nicholls D, Jackson AA. Body mass index cut offs to define thinness in children and adolescents: international survey. BMJ 2007; 335: 194.
37. Zimmet P, Alberti G, Kaufman F etal. The metabolic syndrome in children and adolescents. Lancet 2007; 369: 2059-2061.
38. Barchetta I, Carotti S, Labbadia G etal. Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology 2012; 56: 2180-2187.
39. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease. Diabet. Med. 2005; 22: 1129-1133.
40. Angulo P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002; 346: 1221-1231.
41. Roth CL, Elfers CT, Figlewicz DP etal. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012; 55: 1103-1111.
42. Grunhage F, Hochrath K, Krawczyk M etal. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology 2012; 56: 1883-1891.
43. Adams LA, White SW, Marsh JA etal. Association between liver-specific gene polymorphisms and their expression levels with non-alcoholic fatty liver disease. Hepatology 2012; 57: 590-600.
44. Huang RC, Mori TA, Burke V etal. Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care 2009; 32: 695-701.
45. Hernaez R, Lazo M, Bonekamp S etal. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology 2011; 54: 1082-1090.